SLC35A1 Antibodies

AND SLC35A1 ELISA kits, SLC35A1 Proteins

Many biological assays use antibodies to detect SLC35A1, such as Western Blot (WB), ELISA, Flow Cytometry, Immunocytochemistry (IHC). These antibodies can be polyclonal or monoclonal, and react with SLC35A1 in Human, Mouse, Rat, and many other animal samples. Boster Bio use mainly mouse and rabbit to develop SLC35A1 antibodies...

We validate the specificity of these antibodies to SLC35A1 by testing them on tissues known to express SLC35A1 positively and negatively. Browse below to find the SLC35A1 antibody that suites your experiment. We have 1 of these antibodies and many publications and validation images.

If you cannot find antibodies that fit your needs, contact us for making custom antibodies. We have a full suite of custom antibody services covering from research to diagnostic and therapeutic applications.

Previous: CCN4 Next: IFI44

SLC35A1 Infographic by Boster Bio

All SLC35A1 Products

Filter by Application:

Product

Figures

Specificity

Applications

Price

SLC35A1 (NM_006416) Human Over-expression Lysate

Human

$628
Cat # LS010559
100 µg

SLC35A1 Overview

Facts about CMP-sialic acid transporter.

CMP-sialic acid transporter (SLC35A1)

Transports CMP-sialic acid from the cytosol to Golgi vesicles where glycosyltransferases function. .

Gene Information

Human
Gene Name:	SLC35A1
Uniprot:	P78382
Entrez:	10559

Family

Belongs to:

nucleotide-sugar transporter family

Alternative Names

CMP-sialic acid transporter

Molecular Weight

Mass (kDA):
36.779 kDA

Genomic Context


Human

Location:	6q15
Sequence:	6; NC_000006.12 (87472925..87512339)

Subcellular Localizations

Golgi apparatus membrane; Multi-pass membrane protein.

For details, visit:
bosterbio.com/bosterbio-gene-info-cards/SLC35A1

References

PMID: 9010752 by Ishida N., et al. Molecular cloning and characterization of a novel isoform of the human UDP-galactose transporter, and of related complementary DNAs belonging to the nucleotide-sugar transporter gene family.

PMID: 15576474 by Martinez-Duncker I., et al. Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter.